

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015
AFRICA
19
Overall, there was no significant difference between the
two groups with regard to occurrence of early neurological
outcomes (
n
=
2, 5.8% vs
n
=
1, 4.3%,
p
=
0.12) (Table 3). None
of the patients had revision for bleeding, cardiac tamponade, low
cardiac output syndrome, arrhythmia and systemic, respiratory
or wound infection. The length of intensive care unit stay and
hospital stay were similar between the two groups (Table 3).
Because of the limited sample size (34 vs 23 patients) and very
low occurrence rate of neurological events, the study power (1-
β
error) was quite low (
<
25%) in this study to provide evidence for
rejection of the null hypothesis. When significantly shorter mean
CPB time in group 2 than in group 1 patients (59.6
±
20.8 vs 72.3
±
21.9) was considered as a secondary outcome, our study had
71% power (1-
β
error) with an
α
error of 0.05 and an estimated
effect size of 0.60 (medium effect size).
Discussion
Our study showed that single-stage CEA and CABG is safe and
carotid intervention may be performed either before or after
initiation of CPB without adding much more complexity to the
procedure. However, because of the low effect size, which is a
direct measure of the occurrence rate of the outcomes, our study
could not draw a definitive conclusion regarding the protective
effect of hypothermia during CEA.
The decision whether each patient would receive CEA under
hypothermia or not was the surgeon’s discretion in general,
and this decision was not dependent on objective criteria.
However, it could not be totally neglected that the surgeon might
preferentially have intended to take the short CPB time into
consideration and performed CEA initially in the presence of
certain conditions or features, such as patient fragility or poor
coronary arterial structure. These features were not taken into
consideration as potential risk factors since patient records were
not standardised to provide objective information.
In addition, the majority of our patients were asymptomatic
of neurological complaints, which was another known risk factor
for the development of neurological events after simultaneous
CEA and CABG surgery. The operations were performed
within a period of seven years, in which the standard of surgical
approach did not undergo modification by the surgeon.
Similar to ours, in one earlier study where Di Tommaso
et
al
.
12
performed 73 combined CEA and CABG procedures, the
occurrence rate of temporary neurological deficits was quite low
(five patients), and an additional six patients had cerebrovascular
events during the late follow up. These authors attributed the
low rate of neurological complications to CPB-related benefits,
including haemodilution, pulsatile flow and hypothermia.
Yildirim
et al
.
14
used a similar technique for single-stage
operation and reported that four of 72 patients had neurological
complications and two of these became permanently disabled. In
a report on a small series of patients, neurological events occurred
in one of 15 patients undergoing combined CEA and CABG
under mild hypothermia.
15
Finally, Sadeghi
et al
.
13
reported no
early neurological outcomes and only one stroke during follow
up when CEA was performed under mild hypothermia.
Although all these studies have implied that hypothermia is
likely to have cerebral protective effects, our results and those of
others suggest that the lower complication rates may not only be
produced by the effect of hypothermia but may also be related
to the surgeons’ cumulative experience with the CEA technique.
Darling
et al
.
16
reported in their series of 420 patients that
the risk of stroke was 1.2% and mortality was 2.4% in patients
undergoing CEA prior to CABG. Another study showed that rate
of major stroke was 3.3%, whereas transient neurological deficit
rate was 9.9%
17
in 30 patients undergoing CEA before CABG.
Santos
et al
.
7
recommended a
<
30-day peri-operative period
between initial CEA and CABG. Although some authors
10
have
suggested that the indication for performing combined CEA and
CABG should be restricted to patients requiring urgent CABG,
we believe that a single-stage operation would often be the desired
option both for the surgeon and the patient, provided that there
would be no additional risks using a combined technique.
We are aware that our study had many limitations, including
retrospective design, lack of randomisation, single institution
experience and small sample size. Also, patients in this study
were not divided into treatment arms based on objective criteria,
a fact that may be a source of potential bias. Finally, follow-
up information was not sufficient to report since the majority
of patients could not respond to our invitation for follow up
because they lived in distant regions of the country.
Conclusions
Low rate of adverse neurological outcomes after simultaneous
CABG and CEA under CPB were previously attributed to
hypothermia by a possible mechanism of reducing neuronal
ischaemia. However, our study and previous ones showed that it
is difficult to establish such a relationship due to low occurrence
of adverse outcomes after combined operations. Single-stage
operation is effective and safe, and performing the CEA before
initiation of CPB may be considered when short duration of
CPB is required.
References
1.
Imori Y, Akasaka T, Ochiai T, Oyama K, Tobita 2, Shishido K,
et al
.
Co-existence of carotid artery disease, renal artery stenosis, and lower
extremity peripheral arterial disease in patients with coronary artery
disease.
Am J Cardiol
2014;
113
: 30–35.
2.
Steinvil A1, Sadeh B, Arbel Y, Justo D, Belei A, Borenstein N,
et al
.
Prevalence and predictors of concomitant carotid and coronary artery
atherosclerotic disease.
J Am Coll Cardiol
2011;
57
: 779–783.
3.
Wanamaker KM1, Moraca RJ, Nitzberg D, Magovern GJ Jr.
Contemporary incidence and risk factors for carotid artery disease in
patients referred for coronary artery bypass surgery.
J Cardiothorac
Surg
2012 ;
7
: 78.
4.
Brown KR.Treatment of concomitant carotid and coronary artery
disease. Decision-making regarding surgical options.
J Cardiovasc Surg
(Torino)
2003;
44
: 395–399.
5.
Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL,
McKhann GM. Cognitive and neurologic outcomes after coronary-
artery bypass surgery.
N Engl J Med
2012;
366
: 250–257.
6.
Mortaz Hejri S, Mostafazadeh Davani B, Sahraian MA. Carotid endar-
terectomy for carotid stenosis in patients selected for coronary artery
bypass graft surgery.
Cochrane Database Syst Rev
2009: CD006074.
7.
Santos A, Washington C, Rahbar R, Benckart D, Muluk S. Results
of staged carotid endarterectomy and coronary artery bypass graft in
patients with severe carotid and coronary disease.
Ann Vasc Surg
2012;
26
: 102–106.